Krishna Instit Of Medical Scienc Share Price
Sector: Healthcare Facilities
664.20 -12.30 (-1.82%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
661.35
Today’s High
679
52 Week Low
404.12
52 Week High
707.50
663.10 -13.65 (-2.02%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
661.25
Today’s High
678.90
52 Week Low
406.35
52 Week High
708
Key Metrics
- Market Cap (In Cr) 26577.23
- Beta 0.71
- Div. Yield (%) 0
- P/B 12.67
- TTM P/E 66.6
- Peg Ratio 15.03
- Sector P/E 22.44
- D/E 0.01
- Open Price 679
- Prev Close 676.5
Krishna Instit Of Medical Scienc Analysis
Price Analysis
-
1 Week4.32%
-
3 Months8.71%
-
6 Month14.99%
-
YTD13.17%
-
1 Year58.98%
Risk Meter
- 35% Low risk
- 35% Moderate risk
- 35% Balanced Risk
- 35% High risk
- 35% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 4
- 4
- 4
- 5
- Buy
- 4
- 4
- 4
- 3
- Hold
- 1
- 1
- 1
- 1
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 9
- 9
- 9
- 9
Krishna Instit Of Medical Scienc News
Recommended stocks to buy today, 16 June, by India's leading market experts
6 min read . 16 Jun 2025Recommended stocks to buy today: Top stock picks by market experts for 22 May
9 min read . 22 May 2025Best stock recommendations today: MarketSmith India's top picks for 22 May
4 min read . 22 May 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 18 Mar 2025Krishna Instit Of Medical Scienc Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 3035.1
- Selling/ General/ Admin Expenses Total
- 499.5
- Depreciation/ Amortization
- 177.2
- Other Operating Expenses Total
- 1125.8
- Total Operating Expense
- 2418.6
- Operating Income
- 616.5
- Net Income Before Taxes
- 558.1
- Net Income
- 384.5
- Diluted Normalized EPS
- 9.41
- Period
- 2025
- Total Assets
- 5736
- Total Liabilities
- 3598.2
- Total Equity
- 2137.8
- Tangible Book Valueper Share Common Eq
- 43.27
- Period
- 2025
- Cashfrom Operating Activities
- 582.2
- Cashfrom Investing Activities
- -1116.2
- Cashfrom Financing Activities
- 543.1
- Net Changein Cash
- 9.1
- Period
- 2024
- Total Revenue
- 2498.14
- Selling/ General/ Admin Expenses Total
- 676.96
- Depreciation/ Amortization
- 146.55
- Other Operating Expenses Total
- 22.42
- Total Operating Expense
- 2003.79
- Operating Income
- 494.35
- Net Income Before Taxes
- 459.64
- Net Income
- 310.15
- Diluted Normalized EPS
- 7.74
- Period
- 2024
- Total Assets
- 3852.02
- Total Liabilities
- 2023.66
- Total Equity
- 1828.36
- Tangible Book Valueper Share Common Eq
- 36.38
- Period
- 2024
- Cashfrom Operating Activities
- 521.09
- Cashfrom Investing Activities
- -752.56
- Cashfrom Financing Activities
- 216.76
- Net Changein Cash
- -14.72
- Period
- 2023
- Total Revenue
- 2197.68
- Selling/ General/ Admin Expenses Total
- 564.4
- Depreciation/ Amortization
- 129.26
- Other Operating Expenses Total
- 6.04
- Total Operating Expense
- 1706.63
- Operating Income
- 491.05
- Net Income Before Taxes
- 484.91
- Net Income
- 336.32
- Diluted Normalized EPS
- 8.11
- Period
- 2023
- Total Assets
- 2941.3
- Total Liabilities
- 1271.76
- Total Equity
- 1669.54
- Tangible Book Valueper Share Common Eq
- 32.08
- Period
- 2023
- Cashfrom Operating Activities
- 563.23
- Cashfrom Investing Activities
- -615.6
- Cashfrom Financing Activities
- 88.34
- Net Changein Cash
- 35.98
- Period
- 2022
- Total Revenue
- 1650.83
- Selling/ General/ Admin Expenses Total
- 421.91
- Depreciation/ Amortization
- 72.67
- Other Operating Expenses Total
- 5.33
- Total Operating Expense
- 1203.68
- Operating Income
- 447.14
- Net Income Before Taxes
- 456.85
- Net Income
- 332.69
- Diluted Normalized EPS
- 8.43
- Period
- 2022
- Total Assets
- 1907.35
- Total Liabilities
- 520.04
- Total Equity
- 1387.31
- Tangible Book Valueper Share Common Eq
- 31.76
- Period
- 2022
- Cashfrom Operating Activities
- 324.03
- Cashfrom Investing Activities
- -411.52
- Cashfrom Financing Activities
- 61
- Net Changein Cash
- -26.49
- Period
- 2021
- Total Revenue
- 1329.94
- Selling/ General/ Admin Expenses Total
- 357.9
- Depreciation/ Amortization
- 69.54
- Other Operating Expenses Total
- 4.06
- Total Operating Expense
- 1026.8
- Operating Income
- 303.14
- Net Income Before Taxes
- 279.02
- Net Income
- 201.22
- Diluted Normalized EPS
- 5.05
- Period
- 2021
- Total Assets
- 1436.15
- Total Liabilities
- 572.42
- Total Equity
- 863.73
- Tangible Book Valueper Share Common Eq
- 18.85
- Period
- 2021
- Cashfrom Operating Activities
- 355.97
- Cashfrom Investing Activities
- -354.18
- Cashfrom Financing Activities
- 9.82
- Net Changein Cash
- 11.62
- Period
- 2020
- Total Revenue
- 1122.65
- Selling/ General/ Admin Expenses Total
- 329.18
- Depreciation/ Amortization
- 70.61
- Other Operating Expenses Total
- 3.43
- Total Operating Expense
- 946.22
- Operating Income
- 176.42
- Net Income Before Taxes
- 140.53
- Net Income
- 119.18
- Diluted Normalized EPS
- 3
- Period
- 2020
- Total Assets
- 1195.89
- Total Liabilities
- 597.77
- Total Equity
- 598.13
- Tangible Book Valueper Share Common Eq
- 12.17
- Period
- 2020
- Cashfrom Operating Activities
- 201.5
- Cashfrom Investing Activities
- -124.71
- Cashfrom Financing Activities
- -44.34
- Net Changein Cash
- 32.45
- Period
- 2019
- Total Revenue
- 918
- Selling/ General/ Admin Expenses Total
- 298.76
- Depreciation/ Amortization
- 56.46
- Other Operating Expenses Total
- 3.05
- Total Operating Expense
- 805.44
- Operating Income
- 112.56
- Net Income Before Taxes
- -15.38
- Net Income
- -47.77
- Diluted Normalized EPS
- -1.19
- Period
- 2019
- Total Assets
- 1119.71
- Total Liabilities
- 579.05
- Total Equity
- 540.66
- Tangible Book Valueper Share Common Eq
- 10.97
- Period
- 2019
- Cashfrom Operating Activities
- 133.9
- Cashfrom Investing Activities
- -109.76
- Cashfrom Financing Activities
- -27.04
- Net Changein Cash
- -2.9
- Period
- 2025-03-31
- Total Revenue
- 796.9
- Selling/ General/ Admin Expenses Total
- 134.1
- Depreciation/ Amortization
- 52.6
- Other Operating Expenses Total
- 297.7
- Total Operating Expense
- 640.7
- Operating Income
- 156.2
- Net Income Before Taxes
- 134
- Net Income
- 101.8
- Diluted Normalized EPS
- 2.33
- Period
- 2025-03-31
- Total Assets
- 5736
- Total Liabilities
- 3598.2
- Total Equity
- 2137.8
- Tangible Book Valueper Share Common Eq
- 43.27
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 582.2
- Cashfrom Investing Activities
- -1116.2
- Cashfrom Financing Activities
- 543.1
- Net Changein Cash
- 9.1
- Period
- 2024-12-31
- Total Revenue
- 772.4
- Selling/ General/ Admin Expenses Total
- 127.5
- Depreciation/ Amortization
- 44.7
- Other Operating Expenses Total
- 295.9
- Total Operating Expense
- 629.9
- Operating Income
- 142.5
- Net Income Before Taxes
- 134.6
- Net Income
- 88.7
- Diluted Normalized EPS
- 2.22
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 777.3
- Selling/ General/ Admin Expenses Total
- 119.2
- Depreciation/ Amortization
- 41
- Other Operating Expenses Total
- 284.5
- Total Operating Expense
- 600.2
- Operating Income
- 177.1
- Net Income Before Taxes
- 162.2
- Net Income
- 107.4
- Diluted Normalized EPS
- 2.68
- Period
- 2024-09-30
- Total Assets
- 4578.7
- Total Liabilities
- 2576.7
- Total Equity
- 2002
- Tangible Book Valueper Share Common Eq
- 38.91
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 246.5
- Cashfrom Investing Activities
- -469.5
- Cashfrom Financing Activities
- 239.3
- Net Changein Cash
- 16.3
- Period
- 2024-06-30
- Total Revenue
- 688.4
- Selling/ General/ Admin Expenses Total
- 118.6
- Depreciation/ Amortization
- 39
- Other Operating Expenses Total
- 247.8
- Total Operating Expense
- 548
- Operating Income
- 140.4
- Net Income Before Taxes
- 127.1
- Net Income
- 86.6
- Diluted Normalized EPS
- 2.16
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 633.8
- Selling/ General/ Admin Expenses Total
- 108.54
- Depreciation/ Amortization
- 46.3
- Other Operating Expenses Total
- 231.97
- Total Operating Expense
- 521.13
- Operating Income
- 112.67
- Net Income Before Taxes
- 99.99
- Net Income
- 65.47
- Diluted Normalized EPS
- 1.64
- Period
- 2024-03-31
- Total Assets
- 3852.02
- Total Liabilities
- 2023.66
- Total Equity
- 1828.36
- Tangible Book Valueper Share Common Eq
- 36.38
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 521.09
- Cashfrom Investing Activities
- -752.56
- Cashfrom Financing Activities
- 216.76
- Net Changein Cash
- -14.72
- Period
- 2023-12-31
- Total Revenue
- 605.84
- Selling/ General/ Admin Expenses Total
- 104.25
- Depreciation/ Amortization
- 35.38
- Other Operating Expenses Total
- 228.9
- Total Operating Expense
- 494.09
- Operating Income
- 111.75
- Net Income Before Taxes
- 102.45
- Net Income
- 71.84
- Diluted Normalized EPS
- 1.8
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Krishna Instit Of Medical Scienc Technical
Moving Average
SMA
- 5 Day636.59
- 10 Day652.85
- 20 Day658.37
- 50 Day657.5
- 100 Day619.46
- 300 Day596.19
Krishna Instit Of Medical Scienc Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Global Health
- 1134.5
- 2.6
- 0.23
- 1323.85
- 936.05
- 30441.56
- Aster Dm Healthcare
- 588.1
- -8.5
- -1.42
- 609
- 315.5
- 30470.7
- Krishna Instit Of Medical Scienc
- 664.2
- -12.3
- -1.82
- 707.5
- 404.12
- 26577.23
- Dr. Lal Pathlabs
- 2772.25
- 20.55
- 0.75
- 3645
- 2295.1
- 23292.06
- Rainbow Childrens Medicare
- 1511.05
- 1.1
- 0.07
- 1708.5
- 1079.25
- 15399.32
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Global Health
- 58.41
- 8.94
- 14.18
- 11.38
- Aster Dm Healthcare
- 86.15
- 8.6
- 6.16
- 4.98
- Krishna Instit Of Medical Scienc
- 69.32
- 12.21
- 21.99
- 15.55
- Dr. Lal Pathlabs
- 47.22
- 10.62
- 21.87
- 16.8
- Rainbow Childrens Medicare
- 61.52
- 10.18
- 19.73
- 15.21
Krishna Instit Of Medical Scienc Shareholding
Shareholding Pattern
*Promoter pledging: 4.67%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 12-May-25
- Audited Results
- 06-Feb-25
- Quarterly Results
- 09-Nov-24
- Quarterly Results
- 07-Aug-24
- Quarterly Results
- 28-Jun-24
- Stock Split
- 16-May-24
- Audited Results
- 03-Feb-24
- Quarterly Results
- 07-Nov-23
- Quarterly Results
- 07-Aug-23
- Quarterly Results
- 18-May-23
- Audited Results
- Meeting Date
- Announced on
- Purpose
- 18-Mar-25
- 17-Feb-25
- POM
- 29-Aug-24
- 07-Aug-24
- AGM
- 01-Jan-24
- 30-Nov-23
- POM
- 30-Aug-23
- 18-May-23
- AGM
- 14-Feb-23
- 13-Jan-23
- POM
- 11-Aug-22
- 19-May-22
- AGM
- 13-Jun-22
- 12-May-22
- POM


- Ex-Splits
- Old FV
- New FV
- Description
- 13-Sept-24
- 10
- 2
- Stock split from Rs. 10/- to Rs. 2/-.
